Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Synthesis and preliminary pharmacological evaluation of novel derivatives of L-beta-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3.

Mavencamp TL, Rhoderick JF, Bridges RJ, Esslinger CS.

Bioorg Med Chem. 2008 Aug 15;16(16):7740-8. doi: 10.1016/j.bmc.2008.07.001. Epub 2008 Jul 8.

2.
3.

The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3.

Esslinger CS, Agarwal S, Gerdes J, Wilson PA, Davis ES, Awes AN, O'Brien E, Mavencamp T, Koch HP, Poulsen DJ, Rhoderick JF, Chamberlin AR, Kavanaugh MP, Bridges RJ.

Neuropharmacology. 2005 Nov;49(6):850-61. Epub 2005 Sep 23.

PMID:
16183084
4.

The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.

Bridges RJ, Esslinger CS.

Pharmacol Ther. 2005 Sep;107(3):271-85. Epub 2005 Apr 14. Review.

PMID:
16112332
5.

Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site.

Esslinger CS, Cybulski KA, Rhoderick JF.

Bioorg Med Chem. 2005 Feb 15;13(4):1111-8.

PMID:
15670919
6.

Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport.

Carrigan CN, Bartlett RD, Esslinger CS, Cybulski KA, Tongcharoensirikul P, Bridges RJ, Thompson CM.

J Med Chem. 2002 May 23;45(11):2260-76.

PMID:
12014964
7.

Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters.

Koch HP, Kavanaugh MP, Esslinger CS, Zerangue N, Humphrey JM, Amara SG, Chamberlin AR, Bridges RJ.

Mol Pharmacol. 1999 Dec;56(6):1095-104.

PMID:
10570036
8.

Quinoline-2,4-dicarboxylic acids: synthesis and evaluation as inhibitors of the glutamate vesicular transport system.

Carrigan CN, Esslinger CS, Bartlett RD, Bridges RJ, Thompson CM.

Bioorg Med Chem Lett. 1999 Sep 6;9(17):2607-12.

PMID:
10498218
9.

Structural determinants of substrates and inhibitors: probing glutamate transporters with 2,4-methanopyrrolidine-2,4-dicarboxylate.

Esslinger CS, Koch HP, Kavanaugh MP, Philips DP, Chamberlin AR, Thompson CM, Bridges RJ.

Bioorg Med Chem Lett. 1998 Nov 3;8(21):3101-6.

PMID:
9873684
10.

Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles.

Bartlett RD, Esslinger CS, Thompson CM, Bridges RJ.

Neuropharmacology. 1998 Jul;37(7):839-46.

PMID:
9776380

Supplemental Content

Loading ...
Support Center